聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 10 分钟 36 秒 前

Hansen Medical Announces Exploration of Strategic Alternatives

周四, 01/14/2016 - 13:53
MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, announced today that its board of directors has entered a process to explore strategic alternatives for the compan...
Devices, Cardiology
Hansen Medical, intravascular robotics, Magellan Robotic

Avita Medical Appoints Distributors in Japan and South Korea

周四, 01/14/2016 - 13:46
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Healthcare Sales & Marketing Network) - Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specialising in new treatments for wounds and skin defects, announced...
Devices, Wound Care, Distribution
Avita Medical, ReCell , INDEE Medical, TRM Korea

Oculus Innovative Sciences Receives European CE Mark for New MucoClyns(TM) for First Responders

周四, 01/14/2016 - 13:40
PETALUMA, Calif., Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (OCLS), warrants OCLSW, a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and ...
Biopharmaceuticals, Dermatology, Regulatory
Oculus Innovative Sciences, MucoClyns

Contego Medical Announces European Commercialization of the Paladin(R) Carotid Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology

周四, 01/14/2016 - 13:33
Presenting at the Leipzig Interventional Course (LINC) from January 26th-29th in Leipzig, Germany. RALEIGH, N.C., Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- Contego Medical today announced the European commercialization of the Paladin&r...
Devices, Interventional, Product Launch
Contego Medical, Paladin System, angioplasty balloon, Embolic Protection

FDA Clears Siemens' New High-volume Coagulation Analyzer

周三, 01/13/2016 - 15:47
TARRYTOWN, N.Y.--(Healthcare Sales & Marketing Network)--Siemens Healthcare announces the FDA 510(k) clearance of the globally proven Sysmex CS-5100 System. This hemostasis system was the first to market with PSI technology globally and is now available to...
Diagnostics, Devices, FDA
Siemens Healthcare, Sysmex CS-5100, hemostasis

FDA Clears Siemens’ New High-volume Coagulation Analyzer

周三, 01/13/2016 - 15:47
TARRYTOWN, N.Y.--(Healthcare Sales & Marketing Network)--Siemens Healthcare announces the FDA 510(k) clearance of the globally proven Sysmex CS-5100 System. This hemostasis system was the first to market with PSI technology globally and is now available to...
Diagnostics, Devices, FDA
Siemens Healthcare, Sysmex CS-5100, hemostasis

Command Medical Products Hires John Walter as Director of New Business Development

周三, 01/13/2016 - 15:43
ORMOND BEACH, Fla., Jan. 13, 2016 -- (Healthcare Sales & Marketing Network) -- Command Medical Products is pleased to announce the appointment of John Walter as director of new business development. In this role, Walter will oversee the worldwide new busi...
Devices, Personnel
Command Medical Products

Command Medical Products Hires John Walter as Director of New Business Development

周三, 01/13/2016 - 15:43
ORMOND BEACH, Fla., Jan. 13, 2016 -- (Healthcare Sales & Marketing Network) -- Command Medical Products is pleased to announce the appointment of John Walter as director of new business development. In this role, Walter will oversee the worldwide new busi...
Devices, Personnel
Command Medical Products

Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals

周三, 01/13/2016 - 14:32
Jerry Treppel Resigns NORTHVALE, N.J., Jan. 13, 2016 -- (Healthcare Sales & Marketing Network) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) announced that Jerry Treppel has resigned as the Company’s Chairman and as a m...
Biopharmaceuticals, Personnel
Elite Pharmaceuticals

Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals

周三, 01/13/2016 - 14:32
Jerry Treppel Resigns NORTHVALE, N.J., Jan. 13, 2016 -- (Healthcare Sales & Marketing Network) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) announced that Jerry Treppel has resigned as the Company’s Chairman and as a m...
Biopharmaceuticals, Personnel
Elite Pharmaceuticals

New Study Shows ICU Medical's SwabCap(R) Reduced Central Line-Associated Bloodstream Infections and Blood Culture Contamination, Corresponding To $3.2 Million Annual Savings

周三, 01/13/2016 - 14:27
In commenting on the peer-reviewed study by clinicians at New York City's Memorial Sloan Kettering Cancer Center, an editor for the New England Journal of Medicine noted that use of these devices could "markedly outweigh the added cost" in most i...
Devices
ICU Medical, SwabCap, disinfecting cap

New Study Shows ICU Medical's SwabCap(R) Reduced Central Line-Associated Bloodstream Infections and Blood Culture Contamination, Corresponding To $3.2 Million Annual Savings

周三, 01/13/2016 - 14:27
In commenting on the peer-reviewed study by clinicians at New York City's Memorial Sloan Kettering Cancer Center, an editor for the New England Journal of Medicine noted that use of these devices could "markedly outweigh the added cost" in most i...
Devices
ICU Medical, SwabCap, disinfecting cap

EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering

周三, 01/13/2016 - 14:20
ST. PAUL, Minn., Jan. 13, 2016 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announce...
Devices, Neurology, Venture Capital
EnteroMedics, vBloc Therapy, Maestro, neuromodulation

EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes Offering

周三, 01/13/2016 - 14:20
ST. PAUL, Minn., Jan. 13, 2016 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announce...
Devices, Neurology, Venture Capital
EnteroMedics, vBloc Therapy, Maestro, neuromodulation

Epistem Appoints David Budd as Chief Executive Officer

周三, 01/13/2016 - 14:14
MANCHESTER, England, January 13, 2016 -- (Healthcare Sales & Marketing Network) -- Epistem Holdings Plc (EHP.L), the personalised medicine and biotechnology company, is pleased to announce the appointment of David Budd as Chief Executive Officer and as a ...
Diagnostics, Personalized Medicine, Personnel
Epistem Holdings, Genedrive

Epistem Appoints David Budd as Chief Executive Officer

周三, 01/13/2016 - 14:14
MANCHESTER, England, January 13, 2016 -- (Healthcare Sales & Marketing Network) -- Epistem Holdings Plc (EHP.L), the personalised medicine and biotechnology company, is pleased to announce the appointment of David Budd as Chief Executive Officer and as a ...
Diagnostics, Personalized Medicine, Personnel
Epistem Holdings, Genedrive

Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib

周三, 01/13/2016 - 12:34
MECHELEN, Belgium & FOSTER CITY, Calif.--(Healthcare Sales & Marketing Network)--Galapagos NV (Euronext & NASDAQ:GLPG) and Gilead Sciences, Inc. (GILD) today announced that the U.S. Federal Trade Commission provided early termination of the waiting period ...
Biopharmaceuticals
Gilead Sciences, Galapagos, filgotinib, JAK1

Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib

周三, 01/13/2016 - 12:34
MECHELEN, Belgium & FOSTER CITY, Calif.--(Healthcare Sales & Marketing Network)--Galapagos NV (Euronext & NASDAQ:GLPG) and Gilead Sciences, Inc. (GILD) today announced that the U.S. Federal Trade Commission provided early termination of the waiting period ...
Biopharmaceuticals
Gilead Sciences, Galapagos, filgotinib, JAK1

OptMed Receives FDA Marketing Clearance For Its Topical Surgical Skin Adhesive, BondEase(R)

周二, 01/12/2016 - 22:16
Large Clinical Study Demonstrates First-in-Class Chemistry Affords Effective Wound Closure Rates, Cosmetic Appearance NEW YORK, Jan. 12, 2016 -- (Healthcare Sales & Marketing Network) -- OptMed Inc., a medical device manufacturer, announced today that ...
Devices, Surgery, FDA
OptMed, BondEase, surgical adhesive

OptMed Receives FDA Marketing Clearance For Its Topical Surgical Skin Adhesive, BondEase(R)

周二, 01/12/2016 - 22:16
Large Clinical Study Demonstrates First-in-Class Chemistry Affords Effective Wound Closure Rates, Cosmetic Appearance NEW YORK, Jan. 12, 2016 -- (Healthcare Sales & Marketing Network) -- OptMed Inc., a medical device manufacturer, announced today that ...
Devices, Surgery, FDA
OptMed, BondEase, surgical adhesive

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong